Cardio Diagnostics
In Brief This Week: NIH; Danaher; OpGen; Oncocyte; More
News items for the week of Dec. 4, 2023.
Cardio Diagnostics Publishes Validation Data for Molecular Coronary Heart Disease Test
The new study in the Journal of the American Heart Association shows that the firm's machine learning-based genetic-epigenetic approach can help diagnose coronary heart disease.
Cardio Diagnostics Inks Indian Distribution Pact for Epigenetic Heart Disease Test
The company has entered into a distribution agreement with India's Aimil for its PrecisionCHD test to detect heart disease and personalize its management.
Cardio Diagnostics Enters Private Financing Agreement for up to $11.2M
The firm intends to use the proceeds to accelerate the adoption of its PrecisionCHD and Epi+Gen CHD tests and to launch additional tests.
The firm uses epigenetic and genetic information, along with machine learning to determine a patient's risk of cardiovascular disease.